Status:

COMPLETED

Validation of an ERAS Protocol in Gynecological Surgery

Lead Sponsor:

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Conditions:

Surgery

Hysterectomy

Eligibility:

FEMALE

18-75 years

Phase:

NA

Brief Summary

Validation of ERAS interventional measures in elective gynecological surgery, for benign either malignant pathology.

Eligibility Criteria

Inclusion

  • Age \>18 and \<75 years old
  • Patients candidated for elective gynecological surgery for benign pathology
  • Patients with diagnosis of gynecological neoplasm and candidated for elective gynecological surgery
  • Signed consent form
  • Karnofsky Performance Status \> 70

Exclusion

  • ASA score \> 3
  • Contraindication to loco-regional anaesthesia
  • Patients with ileus or subocclusive condition prior surgery
  • Coagulation disorders
  • Organ failure or severe disfunction (heart, renal, pulmonary, hepatic)
  • Uncontrolled hypertension (\>180/95)
  • Alcohol or drug abuser (current or previous)
  • Unability to self-care (PFS \< 70)
  • Comorbidity-Polypharmacy Score \> 22
  • Psychiatric condition or language barriers
  • Planned Intensive Care Recovery

Key Trial Info

Start Date :

June 14 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2019

Estimated Enrollment :

166 Patients enrolled

Trial Details

Trial ID

NCT03347409

Start Date

June 14 2017

End Date

December 15 2019

Last Update

February 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Federico Ferrari

Brescia, BS, Italy, 25123